课题基金 / 基金详情

Structure and function of memory T cell marker CD26

Structure and function of memory T cell marker CD26
记忆T细胞标志物CD26的结构和功能
批准号:
11694248
负责人:
MORIMOTO Chikao
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

MORIMOTO Chikao的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CD26 is a T cell activation antigen known to bind adenosine deaminase and have dipeptidyl peptidase IV activity. Cross-linking of CD26 and CD3 with immobilized mAbs can deliver a costimulatory signal that contributes to T cell activation. Our earlier studies revealed that cross-linking of CD26 induces its internalization, the phosphorylation of a number of proteins involved in the signaling pathway, and subsequent T cell proliferation. Although these findings suggest the importance of internalization in the function of CD26, CD26 has only 6 aa residues in its cytoplasmic region with no known motif for endocytosis. In the present study, we have identified the mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGFIIR) as a binding protein for CD26 and that mannose 6-phosphate (M6P) residues in the carbohydrate moiety of CD26 are critical for this binding. Activation of peripheral blood T cells results in the mannose 6 phosphorylation of CD26. In addition, the cross-linking of CD26 with an anti-CD26 antibody induces not only capping and internalization of CD26 but also colocalization of CD26 with M6P/IGFIIR.Finally, both internalization of CD26 and the T cell proliferative response induced by CD26-mediated costimulation were inhibited by the addition of M6P, but not by glucose 6-phosphate or mannose 1-phosphate. These results indicate that internalization of CD26 after cross-linking is mediated in part by M6P/IGFIIR and that the interaction between mannose 6-phosphorylated CD26 and M6P/IGFIIR may play an important role in CD26-mediated T cell costimulatory signaling.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
Iwata S,and Morimoto C.: "CD26/Dipeptidyl peptidase IV in context : The different roles of a multifunctional ectoenzyme in malignant transformation"J.Exp.Med.. 190. 305 (301)
Iwata S 和 Morimoto C.:“背景中的 CD26/二肽基肽酶 IV:多功能胞外酶在恶性转化中的不同作用”J.Exp.Med.. 190. 305 (301)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Iwata S,Ohashi Y,Kamiguchi K,Morimoto C: "Beta 1-integrin-mediated cell signaling in T lymphocytes"J Dermatol Sci. 23. 75-86 (2000)
Iwata S、Ohashi Y、Kamiguchi K、Morimoto C:“T 淋巴细胞中 Beta 1-整合素介导的细胞信号传导”J Dermatol Sci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Homma T,Hosono O,Iwata S,Ando S,Sasaki K,Nishi T,Kawasaki H,Tanaka H,Moromoto C: "Recognition of cell surface GD3 by monoclonal antibody anti-6C2 in rheumatoid arthiritis synovial fluid"Arthr.& Rheum. (in press).
Homma T、Hosono O、Iwata S、Ando S、Sasaki K、Nishi T、Kawasaki H、Tanaka H、Moromoto C:“类风湿关节炎滑液中抗 6C2 单克隆抗体对细胞表面 GD3 的识别”Arthr。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ikushima H,Munakata Y,Ishii T,Iwata S,Terashima M,Tanaka H,Schlossman SF,Morimoto C: "Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor I receptor contributes to T cell activation"Proc.Natl.Acad.Sci. 97. 8439-8444 (2000)
Ikushima H、Munakata Y、Ishii T、Iwata S、Terashima M、Tanaka H、Schlossman SF、Morimoto C:“甘露糖 6-磷酸/胰岛素样生长因子 I 受体对 CD26 的内化有助于 T 细胞激活”Proc.Natl
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Association of deubiquitin ligase and cell surface molecules regulates the pathophysiology of malignant pleural mesothelioma
    • 批准号:
      24659401
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    To determine the epigenetic regulatory mechanism of cancer stem cells by cell surface molecules.
    • 批准号:
      22650223
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.12万
    • 财政年份:
      2010
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    Basic research of defining the function of CD26 on human immune system and its clinical application for autoimmune diseases.
    Basic Approach for the Development of Molecular Target Therapy for Autoimmune Diseases and Immune-Mediated Disorders.
    • 批准号:
      17109011
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $71.72万
    • 财政年份:
      2005
    • 负责人:
      MORIMOTO Chikao
    • 依托单位:
    海外基金